The heart is an *omnivorous* organ that relies on both fatty acids and carbohydrates to produce myocardial ATP. Constant supply of ATP through cardiac metabolism is essential to maintain the normal functions of the heart \[[@CR15], [@CR20]\]. In healthy heart, fatty acid-dependent beta-oxidation accounts for 70--90 % of myocardial ATP and the remaining amount is produced through carbohydrate metabolism (such as glucose oxidation and glycolysis) \[[@CR15]\]. However, during disease progression (hypertrophy and early stage heart failure), glucose oxidation and glycolysis become the predominant sources of cellular ATP, indicating a *metabolic shift* from fatty acids to glucose utilization \[[@CR15]\]. At the end stage of heart failure, both glucose metabolism and beta-oxidation are dysregulated, resulting in energy deficiency and impaired myocardial contraction \[[@CR15]\]. Until recently, glucose has been used as the *sole* metabolic substrate in most of cardiac physiological studies (despite the importance of fatty acids in cardiac metabolism). Accordingly, we aim to evaluate the impact of metabolic substrates' supplementation on the mechanisms mediating cardiac contractility in normal rat hearts.

Excitation--contraction (E--C) coupling is the main scheme for the interpretation of myocyte contraction, where Ca^2+^ handling plays a central role to activate the event \[[@CR2], [@CR8]\]. Initially, Ca^2+^ influx through voltage-dependent L-type Ca^2+^ channels (LTCC, I~Ca-L~) triggers more Ca^2+^ to release from the sarcoplasmic reticulum (SR) via ryanodine receptors (RyR). Intracellular Ca^2+^ (\[Ca^2+^\]~i~) binds to troponin C (TnC) in the thin filament (troponin complex), prompts actin association with myosin, and initiates contraction. Reuptake of Ca^2+^ into the SR via Ca^2+^-dependent ATPase (SERCA) and Ca^2+^ extrusion via Na^+^-Ca^2+^ exchanger (NCX) decrease intracellular Ca^2+^, lead to the dissociation of Ca^2+^ from TnC and myosin from actin, myofibril relaxes. As such, factors that increase or decrease the amount of intracellular Ca^2+^ plays important roles in myocardial contractile function. In addition, myofilament Ca^2+^ sensitivity is pivotal in determining myocyte contraction and relaxation in the functioning heart. On the other hand, recent consensus is that changes in the myofilament Ca^2+^ sensitivity, per se, regulates intracellular Ca^2+^ homeostasis and therefore myocyte contractility in normal and diseased hearts \[[@CR4], [@CR11], [@CR19], [@CR21]\]. Until recently, properties of intracellular Ca^2+^ handling and myofilament Ca^2+^ sensitivity in mediating metabolic substrates' regulation of cardiac contractile function has not been reported yet.

Here, we aim to analyze the effects of metabolic substrate supplementation (fatty acids: palmitic acid, linoleic acid, and oleic acid; glucose; pyruvate; and lactate, termed *nutrition with fatty acids*, NF) on myocyte contraction, relaxation, intracellular Ca^2+^ handling, and myofilament Ca^2+^ sensitivity. Our results have shown that myocyte contraction and intracellular Ca^2+^ transients are enhanced and relaxation is facilitated by NF. Increased Ca^2+^ influx via LTCC and, counterintuitively, myofilament Ca^2+^ desensitization by reduced intracellular pH are involved in the effects of NF in rat cardiac myocytes.

Methods and materials {#Sec1}
=====================

Animals and isolation of LV myocytes {#Sec2}
------------------------------------

Sprague--Dawley rats (12 weeks old, male) were anesthetized with pentobarbital sodium (30 mg/kg, i.p.), and the hearts were extracted and rapidly mounted onto the Langendorff perfusion system which were then perfused with a nominal Ca^2+^-free solution for 10 min (in mM; NaCl 135, KCl 5.4, MgCl~2~ 3.5, glucose 5, HEPES 5, Na~2~HPO~4~ 0.4, taurine 20 at pH of 7.4, NaOH), followed by a further 8-min perfusion with the same solution containing collagenase (1 mg/ml, Worthington Biochemical Co.; protease, 0.133 mg/ml, BSA 1.65 mg/ml; Ca^2+^ 0.05 mM). Afterward, the LV free wall was dissected and incubated in fresh collagenase-only solution. Myocytes were harvested following a further 10-min digestion period, washed and resuspended in storage solution (in mM; NaCl 120, KCl 5.4, MgSO~4~ 5, CaCl~2~ 0.2, Na-pyruvate 5, glucose 5.5, taurine 20, HEPES 10, mannitol 29, pH 7.4, NaOH). The myocyte suspension was stored at room temperature and cells were used within 8 h of isolation. The study protocol was in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). It is approved by the Institutional Animal Care and Use Committee (IACUC) in Seoul National University (IACUC approval no.: SNU-101213-1).Scheme 1Schematic diagram of cardiac excitation--contraction coupling in the presence of major metabolic substrates including fatty acids and glucose at physiological concentration. Contraction is enhanced with metabolic substrates' supplementation. Mechanistically, Ca^2+^ influx through LTCC is increased, leads to prolonged APD and greater Ca^2+^ release from the SR, and increases intracellular free Ca^2+^. Reuptake of Ca^2+^ via SERCA is facilitated. Myofilament Ca^2+^ sensitivity is reduced, possibly via reduced pH~i~, which in part is responsible for greater intracellular Ca^2+^ level and decline in rat LV myocytes

Chemical compositions in NT and "nutrition with fatty acids-NF" solution {#Sec3}
------------------------------------------------------------------------

Metabolic substrates (oleic acid 200 μM, palmitic acid 100 μM, linoleic acid 100 μM, lactate 1 mM, pyruvate 100 μM, and carnitine 50 μM) were supplemented to the normal Tyrode solution (NT, in mM: NaCl 141.4, KCl 4, NaH~2~PO~4~ 0.33, MgCl~2~ 1, HEPES 10, glucose 5.5, CaCl~2~ 1.8). Fatty acids (oleic acid, palmitic acid, linoleic acid) were dissolved in 1.35 mM (0.09 g/ml) BSA in NT solution at 70 °C for 3 h to make respective stock solutions (10 mM). The composition and the concentrations of metabolic substrates are modified from blood sample results of normal rats \[[@CR14]\].

Measurement of contraction and Ca^2+^ transients {#Sec4}
------------------------------------------------

Changes in sarcomere length and Ca^2+^ transients were measured in LV myocytes by using a video-sarcomere detection system (IonOptix Corp). For Ca^2+^ measurements, LV myocytes were preincubated with a Ca^2+^ indicator, acetoxymethyl ester of Fura-2 AM (2 μM) in perfusion solution containing 250 μM Ca^2+^ for 15 min at room temperature in the dark. LV myocytes were then washed in perfusion solution containing 500 μM Ca^2+^ for 10 min. The Fura-2 loaded LV myocytes were kept in perfusion solution (500 μM Ca^2+^) before being used. Measurements from at least 10 steady-state contractions were averaged for each myocyte and for each stage of the experimental protocols. All experiments were carried out at 36 ± 1 °C and field stimulated at 2 Hz.

Measurement of myofilament Ca^2+^ sensitivity {#Sec5}
---------------------------------------------

Sarcomere length and Fura-2 ratio (F~360~/F~380~) were recorded simultaneously (field stimulation, 2 Hz). The phase-plane loop of the Fura-2 ratio vs. sarcomere shortening of the same myocyte was plotted and the data were averaged for each group. In each plot, define Fura-2 ratio at 50 % relaxation (EC~50~). Compare both the loop and EC~50~ of each intervention.

Measurement of L-type Ca^2+^ current using whole-cell voltage clamp technique {#Sec6}
-----------------------------------------------------------------------------

L-type Ca^2+^ current (I~Ca~) was measured with whole-cell voltage clamp technique (Axon instrument, 200 A) in LV myocytes in NT and in NF. I~Ca~ was elicited by 200-ms step depolarization protocol from a holding potential of −40 mV to test potentials from −60 mV to +40 mV. Current--voltage relationship, peak current density (pA/pF at 0 mV), and I~Ca~ integral at −20, 0, and +20 mV for 50 ms from the I~Ca~ peak were analyzed. Pipette solution for I~Ca~ measurement contained (in mM) 120 K aspartate, 20 KCl, 10 HEPES, 5 MgATP, 10 NaCl, pH adjusted to 7.2 using KOH.

Measurement of action potential using current clamp technique {#Sec7}
-------------------------------------------------------------

The action potential profile of the myocyte was recorded with current clamp technique in NT and in NF (sampling rate: 10 kHz) at 35--36 °C (Axon Instruments, 200 A). The pipette (resistance 1--2 MΩ) solution contains (in mM) 110 K-aspartate, 30 KCl, 5 NaCl, 10 HEPES, 0.1 EGTA, 5 MgATP, 5 creatine phosphate, and 0.05 cAMP adjusted to pH 7.2.

Measurement of intracellular pH (pH~i~) {#Sec8}
---------------------------------------

Temporal intracellular H^+^ was measured using a membrane-permeant acetoxymethyl ester form of the fluorescent H^+^-sensitive indicator, SNARF-1 AM (10 μM, 5--10 min, Molecular Probes, Eugene, OR). All experiments were performed at 37 °C. In some experiments, pH buffer capacity was increased with NaHCO~3~ (25 mM) + CO~2~ (5 %) instead of HEPES in the perfusion solution to examine the effect of pH on myocyte responses to NF.

### Mathematical modeling {#Sec9}

The endocardial myocyte model by Pandit et al. \[[@CR17]\] was employed to simulate the effects of fatty acids on electrophysiology and Ca^2+^ handling of rat ventricular myocytes.

The effects of intracellular acidosis induced by fatty acids \[[@CR12]\] on cardiac ion channels and Ca^2+^ handling proteins were adopted from the results by Saegusa et al. \[[@CR22]\]. In their report, the simulated effects of intracellular acidosis (\~0.5 U) on I~CaL~ were 24 % reduction in the maximum conductance, 9 mV leftward shift of activation, 3.5 mV leftward shift of inactivation, and 20 % slowing of inactivation. The simulated effects of intracellular acidosis on other cardiac ion channels and transporters were 50 % reduction in maximum conductance of I~to~, 20 % reduction in maximum conductance of I~NaCa~, 40 % reduction in maximum Ca^2+^ flux through RyR channel, and 40 % reduction in maximum pumping rate of sarcoplasmic reticulum Ca^2+^-ATPase (SERCA), respectively. As we assumed the change in intracellular pH to be \~0.1 U, all the changes were scaled down to 1/5 of those from Saegusa et al. \[[@CR22]\] and are summarized in Table [1](#Tab1){ref-type="table"}. The effects of fatty acids on myofilament Ca^2+^-sensitivity were simulated by reducing Ca^2+^ on rates for troponin high- and low-affinity sites (see Table [1](#Tab1){ref-type="table"}).Table 1Model parameters for simulation of the effects of NF on membrane currents and sarcoplasmic reticulum functionParameterUnitDescriptionNTNFg~CaL~nSMaximum conductance for I~CaL~31.00029.512V~h,act,CaL~mVHalf-activation voltage for I~CaL~−15.3−17.1k~act,CaL~mVSlope factor of activation for I~CaL~5.04.8V~h,inact,CaL~mVHalf-inactivation voltage for I~CaL~−26.7−27.4SF~tau,inact,CaL~--Scaling factor for inactivation τ of I~CaL~1.001.04g~to~nSMaximum conductance of I~to~569.2575512.3318k~NaCa~mM^−4^Scaling factor for I~NaCa~9.984·10^−3^9.584·10^−3^ν~1~ms^−1^Maximum RyR (ryanodine) channel Ca^2+^ flux1.8001.656K~SR~--Scaling factor for Ca^2+^-ATPase1.000.92$\documentclass[12pt]{minimal}
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Statistics {#Sec10}
----------

Data were expressed as means ± S.E. or as relative to control (100 %) and *n* indicates the number of cells used. For all comparisons, cells were obtained from a minimum of three hearts per treatment group per protocol. Data were analyzed using Student's *t* test and one-way ANOVA. A value of *P* \< 0.05 was considered to be statistically significant.

Results {#Sec11}
=======

LV myocyte contraction and relaxation with metabolic substrates' supplementation (NF) {#Sec12}
-------------------------------------------------------------------------------------

As shown in Fig. [1a](#Fig1){ref-type="fig"}, [b](#Fig1){ref-type="fig"}, NF increased LV myocyte contraction (*P* \< 0.001 between NT and NF, *n* = 29 & 29) and facilitated relaxation (time to 50 % relaxation, *P* \< 0.02) without changing diastolic sarcomere length (*P* = 0.5). Supplementation of three types of fatty acids (linoic acid, oleic acid and palmitic acid) increased sarcomere shortening (*P* \< 0.01 between NT and 3FA, *n* = 15 and *n* = 15, Fig. [1c](#Fig1){ref-type="fig"}), similar to that observed with NF. These results suggest that metabolic substrates and fatty acids increase myocyte contraction in healthy rat heart.Fig. 1Effect of NF on LV myocyte contraction. **a** Representative raw traces of sarcomere shortening and relengthening in the presence of NF. **b** Mean values of the diastolic sarcomere length and the amplitude of sarcomere shortening (peak height) and 50 % relaxation time (TR~50~). Diastolic sarcomere length was not different between NT and NF. Sarcomere shortening was significantly increased in NF and TR~50~ was shorter by NF. **c** Representatives raw traces and mean values of three fatty acids (3FAs) only on myocyte contraction. 3FAs increased myocyte contraction. **d** Representative raw traces and mean values of a potent antioxidant NAC on myocyte contraction in NF. NAC did not affect the increment of myocyte contraction by NF

Since fatty acids are shown to increase intracellular reactive oxygen species (ROS) in cardiac myocytes \[[@CR20], [@CR27]\], possibly due to increased beta-oxidation in mitochondria and ROS potentiates myocyte contraction in murine heart \[[@CR27]\], we tested whether ROS is responsible for the inotropic effect of metabolic substrates. Incubation of LV myocytes with a potent antioxidant, N-acetyl-cysteine (NAC, 100 μM), did not prevent NF augmentation of myocyte contraction (*P* \< 0.001 between NT + NAC and NF + NAC, *n* = 16, Fig. [1d](#Fig1){ref-type="fig"}). These results exclude the role of ROS in mediating NF-induced myocyte contraction in rat hearts.

Intracellular Ca^2+^ transient (\[Ca^2+^\]~i~) with NF {#Sec13}
------------------------------------------------------

Next, we tested whether NF increased \[Ca^2+^\]~i~. As shown in Fig. [2a](#Fig2){ref-type="fig"}, [b](#Fig2){ref-type="fig"}, NF significantly increased the diastolic and systolic \[Ca^2+^\]~i~ (F~360~/~380~: *P* \< 0.001 and *P* \< 0.001, *n* = 18, *n* = 18). Analysis of \[Ca^2+^\]~i~ profile showed that the time constant of \[Ca^2+^\]~i~ decay (tau, ms) was abbreviated in NF (*P* \< 0.001, Fig. [2b](#Fig2){ref-type="fig"}). Nevertheless, the peak \[Ca^2+^\]~i~ duration (90 % peak time + 10 % time to relaxation, PT~90~ + TR~10~) and TR~50~ of \[Ca^2+^\]~i~ were prolonged (*P* = 0.009 and *P* = 0.002, *n* = 18 and *n* = 18, respectively). These results suggest that NF increased \[Ca^2+^\]~i~ transients and decay kinetics of \[Ca^2+^\]~i~ but prolonged peak time of \[Ca^2+^\]~i~ during systole.Fig. 2NF regulation of intracellular Ca^2+^ transients. **a** Representative \[Ca^2+^\]~i~ transients in NT and NF. **b** Mean values of \[Ca^2+^\]~i~ transient parameters. NF significantly increased diastolic \[Ca^2+^\]~i~ and peak amplitude of \[Ca^2+^\]~i~. Time to 50 % relaxation and peak time duration (PT~90~ + TR~10~) were prolonged; however, time constant of \[Ca^2+^\]~i~ decay (tau) was facilitated in NF

L-type Ca^2+^ current (I~Ca~) and action potential profile with NF {#Sec14}
------------------------------------------------------------------

We aimed to test the key elements of excitation-contraction coupling responsible for increased myocyte \[Ca^2+^\]~i~ and contraction in NF. Figure [3a](#Fig3){ref-type="fig"}, [b](#Fig3){ref-type="fig"} showed raw traces and averaged current--voltage (I--V) relationships of I~Ca~ in LV myocytes before and after NF. And the inset in Fig. [3a](#Fig3){ref-type="fig"} showed raw traces of I~Ca~ at 0 mV for Ca^2+^ influx analysis. NF reduced the amplitude of I~Ca~ at 0 mV (current density of I~Ca~ at 0 mV, pA/pF: *P* = 0.03 between NT and NF, *n* = 34, *n* = 11) but slowed the inactivation of I~Ca~ at 0 mV (in ms, tau~slow~: *P* = 0.005; tau~fast~: *P* = 0.3, Fig. [3c](#Fig3){ref-type="fig"}). As a result, total Ca^2+^ influx via LTCC (integral of I~Ca~) was greater in NF (*P* = 0.05 between NT and NF at 0 mV, Fig. [3d](#Fig3){ref-type="fig"}). Similarly, integral of I~Ca~ was bigger at −20 mV (P = 0.05) but not at +20 mV.Fig. 3Patch-clamp recordings of LTCC activities in NF. **a**, **b** Pulse protocol, representative I~Ca~ and the corresponding I-V relationship, peak I~Ca~ at 0 mV, inactivation parameters, and the integral of Ca^2+^ influx in NF. NF reduced peak I~Ca~ density, prolonged slow inactivation of I~Ca~, and increased integral of I~Ca~ at 0 mV and −20 mV

Greater I~Ca~ influx in NF may be responsible for the prolongations of action potential (AP) plateau (and therefore APD) and \[Ca^2+^\]~i~ duration. Accordingly, we examined the APD duration in NF. As shown in Fig. [4a](#Fig4){ref-type="fig"}, [b](#Fig4){ref-type="fig"}, APD~20~, APD~50~, and APD~90~ were significantly prolonged in NF (*P* \< 0.05, *P* \< 0.05, and *P* \< 0.05, *n* = 12). Collectively, these results suggest that Ca^2+^ influx via LTCC is greater and APD is prolonged, which may be responsible for increased \[Ca^2+^\]~i~ amplitudes and prolonged peak time of \[Ca^2+^\]~i~ in NF.Fig. 4Effect of NF on action potential profile. **a** Representative action potential profile in NT and NF. **b** Mean value of action potential duration parameters. NF significantly prolonged the repolarization duration of APD (APD20, APD50, APD90)

Myofilament Ca^2+^ sensitivity with NF {#Sec15}
--------------------------------------

To test whether myofilament Ca^2+^ sensitivity is regulated by NF and contributes to greater contraction and faster relaxation, we recorded sarcomere shortening and \[Ca^2+^\]~i~ simultaneously in Fura-2-loaded LV myocytes and plotted a phase-plane loop of the changes in sarcomere length vs. \[Ca^2+^\]~i~ transient with and without NF. As shown in Fig. [5a](#Fig5){ref-type="fig"}, [b](#Fig5){ref-type="fig"}, relaxation phase of the sarcomere length-\[Ca^2+^\]~i~ transient relationship shifted to the right in NF; \[Ca^2+^\]~i~ at 50 % sarcomere relengthening (EC~50~) was significantly increased (*P* \< 0.001, *n* = 18). These results suggest that myofilament Ca^2+^ sensitivity was significantly reduced by NF.Fig. 5NF regulation of myofilament Ca^2+^ sensitivity. **a** Simultaneous recordings of LV myocyte sarcomere shortening/relengthening and intracellular Ca^2+^ transients in NT and in NF. **b** Phase-plane loop of sarcomere shortening/relengthening vs. \[Ca^2+^\]~i~ transient. The relaxation phase of the loop shifted to the right in NF compared to that in NT. Ca^2+^ concentration at 50 % sarcomere relengthening (EC~50~) was significantly larger in NF

Myofilament Ca^2+^ desensitization regulates \[Ca^2+^\]~i~ in NF {#Sec16}
----------------------------------------------------------------

Myofilament buffers Ca^2+^ and changing myofilament Ca^2+^ sensitivity affects \[Ca^2+^\]~i~ homeostasis \[[@CR4], [@CR11]\]. Accordingly, we tested whether myofilament Ca^2+^ desensitization with a potent myosin ATPase inhibitor, BDM, prevents increased \[Ca^2+^\]~i~ and facilitated tau of \[Ca^2+^\]~i~ in NF. As shown in Fig. [6a](#Fig6){ref-type="fig"}, [b](#Fig6){ref-type="fig"}, incubation of LV myocytes with BDM (5 mM) abolished NF-induced increase in diastolic and systolic \[Ca^2+^\]~i~ and faster tau (*P* = 0.8 in diastole; *P* = 0.22 in systole; *P* = 0.96 for tau between NT and NF with BDM; *n* = 12). These results suggest that reduced myofilament Ca^2+^sensitivity in NF may, *at least in part*, increase \[Ca^2+^\]~i~ and facilitate \[Ca^2+^\]~i~ decline in rat LV myocytes. The duration of \[Ca^2+^\]~i~ peak (90 % time to peak +10 % \[Ca^2+^\]~i~ decline, PT~90~ + TR~10~), however, remain prolonged in NF in the presence of BDM (*P* \< 0.001, between NT + BDM and NF + BDM, *n* = 12, Fig. [6b](#Fig6){ref-type="fig"}).Fig. 6Effect of NF on \[Ca^2+^\]~i~ in BDM-pretreated LV myocytes. Representative \[Ca^2+^\]~i~ (**a**) and mean vales of \[Ca^2+^\]~i~ transient parameters (**b**). NF-induced increase in diastolic and systolic \[Ca^2+^\]~i~ were abolished by BDM (5 mM). Time constant of Ca^2+^ decay (tau) was not facilitated in NF in the presence of BDM. Peak time duration remained unaltered by BDM pretreatment

Regulation of intracellular pH~i~ by NF {#Sec17}
---------------------------------------

To investigate whether intracellular pH (\[pH~i~\]) is reduced by NF and contributes to reduced myofilament Ca^2+^ sensitivity, we detected changes of pH~i~ in SNARF-1/AM-loaded LV myocytes. As shown in Fig. [7a](#Fig7){ref-type="fig"}, the pH~i~ was gradually decreased with NF (3--5 min). Averaged results showed that NF significantly reduced pH~i~ (*P* = 0.03, *n* = 10, Fig. [7b](#Fig7){ref-type="fig"}).Fig. 7NF regulation of intracellular pH~i~. **a** Representative recording of pH~i~ in NT and NF using HEPES buffer. **b** Mean values of pH~i~ in NT and NF, pH~i~ was significantly reduced by NF

Increasing pH buffer capacity in NF using NaHCO~3~ + CO~2~ (5 %) weaken the changes in pH~i~ by NF (Supplementary Fig. [1a](#MOESM1){ref-type="media"}, [b](#MOESM1){ref-type="media"}). Importantly, such a modification in pH~i~ abolished NF-induced myofilament Ca^2+^ desensitization, increase in the amplitude of \[Ca^2+^\]~i~ and the prolongation of the peak time of \[Ca^2+^\]~i~ (supplementary Fig. [2a](#MOESM2){ref-type="media"}, [b](#MOESM2){ref-type="media"}). These results suggest that reduced pH~i~ may play an important role in mediating the effects of NF on the myofilament Ca^2+^ sensitivity and its regulation of \[Ca^2+^\]~i~ handling.

Computer simulation of I~Ca~, \[Ca^2+^\]~i~ and APD with NF {#Sec18}
-----------------------------------------------------------

Next, we employed the computer simulation to further confirm whether reduced pH~i~ and concomitant myofilament Ca^2+^-desensitization affect \[Ca^2+^\]~i~, I~Ca~, and AP in the same way as NF. Indeed, the peak amplitude of \[Ca^2+^\]~i~ was increased from 1.34 to 1.63 μM, qualitatively similar to the experimental results in Fig. [2](#Fig2){ref-type="fig"} (Fig. [8a](#Fig8){ref-type="fig"}). In addition, peak \[Ca^2+^\]~i~ duration was also prolonged (Fig. [8a](#Fig8){ref-type="fig"}), in line with the results observed in Fig. [2b](#Fig2){ref-type="fig"}. I--V relationship of I~Ca~ and the peak I~Ca~ at 0 mV were slightly reduced in the simulation while the integral of I~Ca~ was increased (Fig. [7b](#Fig7){ref-type="fig"}). In addition, the AP duration was prolonged in the simulation (APD~50~ from 32.8 to 37.4 ms and APD~90~ from 82.6 to 96.4 ms), which is in line with the experimental results.Fig. 8Simulated effects of NF on electrical properties and Ca^2+^ regulation of rat ventricular myocytes. Ca^2+^ transient morphology (**a**), I~CaL~ (**b**), and APD (**c**), **a** Simulated effects of NF on morphology and relaxation time of Ca^2+^ transient. Measurements of 50 % relaxation time and peak time duration were conducted in the same way as those in Fig. [2b](#Fig2){ref-type="fig"}. The *dashed line* indicates 10 nM \[Ca^2+^\]~i~ level. **b** Simulated effects of NF on I~CaL~ and Ca^2+^-influx through I~CaL~. The *left panel* shows the effects of NF on I~CaL~ during AP. The middle panel compares the total Ca^2+^ influx through I~CaL~ between NT and NF. The right panel shows the effects of NF on I~CaL~ density obtained by a voltage-clamp protocol used in animal experiments (see Fig. [3b](#Fig3){ref-type="fig"}). The dashed line indicates zero current level. **c** Simulated effects of NF on morphology and duration of AP. Pacing frequency is 1 Hz. APD50 was calculated as the difference between time at 50 % depolarization and time at 50 % repolarization. APD90 was calculated as the difference between time at 10 % depolarization and time at 90 % repolarization. The *dashed line* indicates zero voltage level

Discussion {#Sec19}
==========

The present study showed that supplementation of metabolic substrates (including fatty acids, physiological concentration of glucose) increased LV myocyte contraction and facilitated relaxation from rat heart by increasing Ca^2+^ influx via LTCC and increasing \[Ca^2+^\]~i~ transients, despite that myofilament Ca^2+^ sensitivity was reduced. Importantly, both experimental and computer simulation results suggest that myofilament Ca^2+^ desensitization, at least in part, contributes to increased \[Ca^2+^\]~i~ , greater contraction, abbreviated tau, and faster relaxation by NF. Intracellular pH, which is reduced by NF, is important in mediating the effects of NF on myocyte contraction, relaxation, and \[Ca^2+^\]~i~. These results suggest that supplementation of metabolic substrates (including fatty acids) potentiates myocyte inotropy and lusitropy by regulating key elements of Ca^2+^ handling processes and myofilament Ca^2+^ sensitivity, in addition to their effects on cardiac metabolism.

The main theme of the study was that supplementation of metabolic substrates essential for cardiac metabolism (e.g. FAs for beta-oxidation in addition to glucose, NF) influenced myocyte function from normal rat hearts. That is, NF enhanced LV myocyte contraction and promoted myocyte relaxation in almost all the myocytes studied. Furthermore, NF increased diastolic and systolic \[Ca^2+^\]~i~, facilitated Ca^2+^ reuptake into the SR via SERCA, and prolonged peak time duration of \[Ca^2+^\]~i~. Since LTCC and Ca^2+^ release from the SR are important in shaping AP and \[Ca^2+^\]~i~ profiles and myofilament Ca^2+^ sensitivity and myofilament mechanics dominate myocyte contraction, we analyzed these parameters in the presence of NF. As shown in both experimental and computer simulation results, peak I~Ca~ density was reduced by NF; however, the integral of I~Ca~ (total Ca^2+^ influx) was increased due to slower inactivation of LTCC (especially at the voltage range of AP plateau, −20 and 0 mV), suggesting more Ca^2+^ is fluxed into the myocyte under these conditions. Accordingly, APD was prolonged remarkably with NF. These results suggest that \[Ca^2+^\]~i~ elevation with NF may be due to increased Ca^2+^ influx via LTCC and the changes in LTCC are likely responsible for the prolongations of APD and the peak duration of \[Ca^2+^\]~i~.

NF regulation of myofilament Ca^2+^ sensitivity was analyzed in contracting LV myocytes. Our results showed a significant reduction in myofilament Ca^2+^ sensitivity with NF but myocyte contraction was increased. The seemingly counterintuitive results stress the importance of Ca^2+^ handling in greater myocyte contraction with NF. It should be noted that alterations in the myofilament Ca^2+^ sensitivity, in general, is associated with changes in Ca^2+^ binding affinity to TnC and \[Ca^2+^\]~i~ buffering capacity \[[@CR11], [@CR19]\]. For example, Robinson et al. showed that the Ca^2+^ binding affinity of the myofilament complex was reduced in dilated cardiomyopathy due to the mutations in thin filament, where myofilament Ca^2+^ sensitivity was reduced \[[@CR19]\]. Conversely, hypertrophic cardiomyopathy with myofilament Ca^2+^-sensitizing mutant increased Ca^2+^-binding affinity and Ca^2+^ buffering \[[@CR19], [@CR21]\]. In fact, previous results from our laboratory have shown that myofilament Ca^2+^ desensitization in LV myocytes from angiotensin II-induced hypertensive rat hearts was associated with greater \[Ca^2+^\]~i~ \[[@CR13]\] and myofilament Ca^2+^ desensitization with BDM increased \[Ca^2+^\]~i~ in sham but not in hypertension (where myofilament Ca^2+^ sensitivity was reduced). Furthermore, myofilament Ca^2+^ desensitization in hypertension, with BDM or with high stimulation frequency, prompted greater I~Ca~ inhibition due to \[Ca^2+^\]~i~ increment \[[@CR25]\]. Here, the current findings that myofilament Ca^2+^ desensitization with BDM prevented NF-induced increase in the amplitude of \[Ca^2+^\]~i~ are consistent to our previous results. Furthermore, computer simulation with reduced Ca^2+^ binding and myofilament Ca^2+^ desensitization recapitulated greater \[Ca^2+^\]~i~ and the prolongation of the peak duration of \[Ca^2+^\]~i~, supporting the experimental results with NF. These results strongly suggest that both LTCC and myofilament contribute to increased \[Ca^2+^\]~i~ and myocyte contraction/relaxation with NF in rat heart.

Multiple mechanisms may underlie the regulation of myofilament Ca^2+^ sensitivity and LTCC by NF. It is possible that enhanced mitochondrial activity secondary to the supplementation of metabolic substrates may produce greater ROS via oxidative phosphorylation \[[@CR15]\] and ROS can potentiate myocyte contraction via the activation of second messengers including protein kinase A (PKA) \[[@CR6], [@CR27]\]. As such, we tested whether intracellular ROS is involved in greater myocyte contraction with NF. Although we did not detect the ROS production from LV myocytes with NF, preincubation with a potent antioxidant, NAC failed to prevent the effect of NF on myocyte shortening. Furthermore, inhibition of PKA (with membrane permeable PKA inhibitor, PKA-amide 14-22) failed to affect NF regulation of myocyte contraction (data not shown). These results excluded the involvement of ROS in mediating the effect of NF.

Our results showed that intracellular pH was reduced by NF. Since low pH is a potent modulator of myofilament Ca^2+^ sensitivity in cardiac and skeletal muscle \[[@CR1], [@CR9], [@CR16], [@CR24]\], reduced pH may mediate the reduced myofilament Ca^2+^ sensitivity and the subsequent regulation of \[Ca^2+^\]~i~. To confirm, when intracellular pH buffering was increased with NaHCO~3~ + CO~2~, the effects of NF on myofilament Ca^2+^ sensitivity and \[Ca^2+^\]~i~ were diminished. Alternatively, reduced pH may increase \[Ca^2+^\]~i~ via enhancing the activity of Na^+^-H^+^ exchanger and the reverse mode of cardiac Na^+^-Ca^2+^ exchanger \[[@CR5]\]. It is possible that increased cellular metabolic status in NF reduced intracellular pH. Alternatively, it is well established that pyruvate or lactate enters the myocyte with one proton through the sarcolemmal monocarboxylate-proton symporter \[[@CR7]\] and consequently reduces intracellular pH \[[@CR18]\]. Mechanism leading to the changes in intracellular pH needs further investigation.

Another possible mechanism for myofilament Ca^2+^ desensitization is intracellular ATP. This is because ATP desensitizes myofilament response to Ca^2+^ in muscle and myocardium \[[@CR3], [@CR10]\]. Preliminary results showed that cellular ATP level tended be elevated in normal rat LV myocyte homogenates preincubated with palmitic acid (30 min) (data not shown). The level of ATP was not detected with NF due to the lack of possibility for real-time temporal measurement in the current experimental setting. The details of myofilament Ca^2+^ desensitization and myofilament buffering of Ca^2+^ with metabolic substrates need further investigation.

Simulated effects of NF on Ca^2+^ transients, I~CaL~, and AP {#Sec20}
------------------------------------------------------------

Most of experimentally observed effects of NF on AP, Ca^2+^ transients, and I~Ca~ were successfully reproduced by computer simulation which assumed that the effects of NF are all mediated by lowered intracellular pH. Saegusa et al. \[[@CR22]\] proposed that the increased H^+^ concentration at low intracellular pH affects I~Ca~ by modulating charge screening/binding of surface charge and permeability of LTCC. As NF was found to reduce intracellular pH \~0.1 U (Fig. [8a](#Fig8){ref-type="fig"}) in our experimental condition, modifications proposed by Saegusa et al. \[[@CR22]\] were all scaled down to 1/5 and were applied to our simulation. The increased intracellular H^+^ is also known to raise intracellular Ca^2+^ by unloading Ca^2+^ from Ca^2+^-buffering proteins (coupled Ca^2+^/H^+^ transport by cytoplasmic buffers regulates local Ca^2+^ and H^+^ ion signaling \[[@CR23]\]). In our simulation, the ability of increased intracellular H^+^ to unload Ca^2+^ from Ca^2+^-buffering proteins was embodied by assuming it reduces Ca^2+^ on rates for TnC. Therefore, the effects of NF were reproduced in our simulation by assuming that L-type Ca^2+^ channels and Ca^2+^-buffering are both affected in response to increased intracellular H^+^. The altered LTCC was found to be responsible for both increased amplitude of Ca^2+^ transients and the prolongation of AP in our simulation, whereas the altered Ca^2+^-buffering was found to be mainly responsible for increased amplitude of Ca^2+^ transients rather than prolongation of AP (data not shown).

In conclusion, our results clearly show that supplementation of metabolic substrates, including fatty acids, is important in strengthening cardiac metabolism and contractile function. Under these conditions, Ca^2+^ handling processes and myofilament play in concert to potentiate intracellular Ca^2+^ level and induce greater contraction. Our results provide useful evidence for better understanding of cardiac excitation--contraction coupling with comprehensive metabolic supplies.
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